yes, I jumped in as well, at 16.99. I have owned Amedisys before, but when I was looking at getting back in to this depressed sector I discovered AFAM. I think they look signficantly superior to AMED
All on this thread have made a good call and are accurate. I've been around this one for a while, the % return I think will be excllent, it's just the time frame I'm impatient on.
It looks likely that the industry will see margins decline, but this has taken a MUCH worse haircut than it should have. I would consider 25$ per-share a cheap price for this, so it's a steal at 16 IMO